Long-Term Specified Drug Use-Results Survey for Xtandi Capsule

Clinical trial NCT02669771 · COMPLETED

Trial details

NCT number: NCT02669771
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Study type: OBSERVATIONAL

Castration-resistant Prostate Cancer

Start date: 2014-11-30
Primary completion: 2018-11-30
Enrollment: 1018

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.